Most sold healthcare stocks in Q1 2022
See which Healthcare stocks institutional investors trimmed or exited the most in Q1 2022, measured as net reductions in reported share positions from Q4 2021 into Q1 2022. Notable reductions at the top of this list include JOHNSON & JOHNSON (JNJ), TAKEDA PHARMACEUTIC-SP ADR (TAK), BRISTOL-MYERS SQUIBB CO (BMY), AVANTOR INC (AVTR). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | -7,813,056 | -$1.26B | 1 | 9 | 9 | 3 | 26 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | -7,548,539 | -$100.39M | 1 | 2 | 1 | 2 | 4 |
| BMY | BRISTOL-MYERS SQUIBB CO | -7,439,211 | -$55.36M | 0 | 10 | 9 | 3 | 22 |
| AVTR | AVANTOR INC | -6,505,662 | -$436.45M | 2 | 2 | 2 | 0 | 7 |
| BSX | BOSTON SCIENTIFIC CORP | -5,919,151 | -$197.80M | 1 | 3 | 3 | 1 | 7 |
| TLRY | TILRAY BRANDS INC | -4,936,397 | -$34.48M | 0 | 1 | 1 | 0 | 2 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | -4,527,722 | -$93.87M | 0 | 0 | 2 | 2 | 2 |
| ABBV | ABBVIE INC | -4,523,602 | -$553.06M | 1 | 3 | 8 | 4 | 16 |
| AHCO | ADAPTHEALTH CORP | -3,949,783 | -$96.64M | 0 | 0 | 0 | 1 | 1 |
| CLLS | CELLECTIS - ADR | -2,941,556 | -$23.89M | 0 | 0 | 0 | 1 | 0 |
| HUM | HUMANA INC | -2,798,230 | -$1.30B | 0 | 2 | 1 | 3 | 5 |
| EDIT | EDITAS MEDICINE INC | -2,745,761 | -$85.70M | 0 | 1 | 1 | 0 | 2 |
| UNH | UNITEDHEALTH GROUP INC | -2,672,767 | -$1.19B | 1 | 7 | 20 | 1 | 30 |
| ZTS | ZOETIS INC | -2,383,874 | -$1.25B | 1 | 5 | 7 | 1 | 14 |
| GDRX | GOODRX HOLDINGS INC-CLASS A | -2,331,004 | -$81.57M | 0 | 2 | 0 | 3 | 2 |
| PRCT | PROCEPT BIOROBOTICS CORP | -1,960,694 | -$1.26M | 0 | 0 | 2 | 1 | 2 |
| SENS | SENSEONICS HOLDINGS INC | -1,873,400 | -$5.33M | 0 | 0 | 1 | 0 | 1 |
| AGL | AGILON HEALTH INC | -1,578,486 | -$47.55M | 0 | 0 | 1 | 1 | 1 |
| SNY | SANOFI-ADR | -1,446,594 | $42.48M | 0 | 3 | 2 | 1 | 6 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | -1,393,326 | -$87.98M | 0 | 0 | 3 | 0 | 3 |
| ACCD | ACCOLADE INC | -1,290,864 | -$80.68M | 0 | 0 | 2 | 1 | 2 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -1,261,799 | -$26.39M | 0 | 2 | 3 | 1 | 7 |
| BLRX | BIOLINERX LTD-SPONS ADR | -1,006,476 | -$2.08M | 0 | 1 | 0 | 1 | 1 |
| THC | TENET HEALTHCARE CORP | -977,479 | -$70.31M | 1 | 0 | 1 | 0 | 3 |
| HSIC | HENRY SCHEIN INC | -920,296 | -$63.72M | 1 | 2 | 1 | 1 | 4 |
| AMGN | AMGEN INC | -841,325 | -$167.53M | 0 | 7 | 3 | 2 | 12 |
| CAH | CARDINAL HEALTH INC | -816,139 | -$20.62M | 1 | 1 | 3 | 2 | 6 |
| EVH | EVOLENT HEALTH INC - A | -809,696 | $10.68M | 0 | 0 | 1 | 1 | 1 |
| CNC | CENTENE CORP | -779,476 | -$49.69M | 0 | 3 | 3 | 1 | 6 |
| NVS | NOVARTIS AG-SPONSORED ADR | -770,871 | -$58.34M | 0 | 2 | 5 | 3 | 9 |
| ARDX | ARDELYX INC | -744,828 | -$858.00K | 0 | 0 | 1 | 0 | 1 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -735,290 | -$99.87M | 0 | 2 | 3 | 1 | 6 |
| MPLN | MULTIPLAN CORP | -716,600 | -$3.10M | 0 | 0 | 1 | 0 | 1 |
| PMVP | PMV PHARMACEUTICALS INC | -714,284 | -$18.95M | 0 | 0 | 1 | 0 | 1 |
| OPCH | OPTION CARE HEALTH INC | -663,090 | -$18.75M | 0 | 1 | 1 | 1 | 2 |
| DH | DEFINITIVE HEALTHCARE CORP | -617,000 | -$17.14M | 0 | 0 | 1 | 1 | 1 |
| PPBT | PURPLE BIOTECH LTD-ADR | -612,219 | -$2.38M | 1 | 0 | 0 | 1 | 1 |
| NVST | ENVISTA HOLDINGS CORP | -597,596 | -$4.99M | 1 | 1 | 2 | 0 | 4 |
| NUVL | NUVALENT INC-A | -537,501 | -$15.95M | 0 | 0 | 1 | 0 | 1 |
| TFX | TELEFLEX INC | -526,595 | -$171.46M | 0 | 1 | 3 | 2 | 4 |
| VRTX | VERTEX PHARMACEUTICALS INC | -470,734 | $14.03M | 0 | 3 | 3 | 3 | 6 |
| TALK | TALKSPACE INC | -426,436 | -$871.00K | 0 | 0 | 1 | 0 | 1 |
| AMED | AMEDISYS INC | -395,968 | -$64.06M | 1 | 0 | 0 | 2 | 3 |
| TDOC | TELADOC HEALTH INC | -384,882 | -$431.32M | 0 | 2 | 3 | 2 | 5 |
| CI | THE CIGNA GROUP | -328,762 | $108.39M | 2 | 3 | 4 | 1 | 10 |
| SVRA | SAVARA INC | -327,792 | -$403.95K | 0 | 0 | 1 | 0 | 2 |
| CRON | CRONOS GROUP INC | -307,966 | -$1.21M | 0 | 1 | 0 | 1 | 1 |
| IBRX | IMMUNITYBIO INC | -304,900 | -$1.85M | 0 | 0 | 0 | 1 | 0 |
| ALGN | ALIGN TECHNOLOGY INC | -286,905 | -$801.91M | 0 | 5 | 2 | 2 | 7 |
| ILMN | ILLUMINA INC | -285,050 | -$204.71M | 0 | 3 | 4 | 1 | 7 |
Frequently asked questions about Most sold healthcare stocks in Q1 2022
What are the most sold Healthcare stocks in Q1 2022?
The most sold healthcare stocks in Q1 2022 are those with the largest decrease in reported share counts across institutional investors compared to Q4 2021, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q1 2022?
Among filers in this sector, net reductions were largest in companies such as JOHNSON & JOHNSON (JNJ), TAKEDA PHARMACEUTIC-SP ADR (TAK), BRISTOL-MYERS SQUIBB CO (BMY), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2021).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.